TAK1 activates MAPKs and subsequently triggers the activation of various transcription factors including interferon regulatory factors (IRF)3, IRF5, and IRF7, that have been previously described as risk factors for SLE (32–36), and NF-κB (29–31). The gene discussed is IRF5; the disease is systemic lupus erythematosus.